Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bubu A Banini

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The American Journal of Gastroenterology|June 21, 2017
Corrigendum: Treatment of NASH: What Helps Beyond Weight Loss?Bubu A Banini, Arun J Sanyal
Current Opinion in Gastroenterology|March 28, 2017
Current and future pharmacologic treatment of nonalcoholic steatohepatitisBubu A Banini, Arun J Sanyal
Advances in Cancer Research|February 13, 2021
NAFLD-related HCCBubu A Banini, Arun J Sanyal
Hepatoma Research|November 2, 2019
The use of cell free DNA in the diagnosis of HCCBubu A Banini, Arun J Sanyal
Current Treatment Options in Gastroenterology|May 12, 2019
Updates on Chronic HBV: Current Challenges and Future GoalsHannah M Lee, Bubu A Banini
Clinical Medicine Insights. Therapeutics|July 4, 2017
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment OptionsBubu A Banini, Arun J Sanyal
Digestive Diseases and Sciences|May 9, 2022
Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?Jennifer C Asotibe, Bubu A Banini
The American Journal of Gastroenterology|April 12, 2017
Treatment of NASH: What Helps Beyond Weight Loss?Bubu A Banini, Arun J Sanyal
Annals of the New York Academy of Sciences|July 3, 2023
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategiesGeorge Agyapong, Farzaneh Dashti, Bubu A Banini
Frontiers in Oncology|August 8, 2022
Editorial: Recent advances in the understanding of hepatocellular carcinogenesisBubu A Banini, Rohini Mehta, Prasanna K Santhekadur
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The American Journal of Gastroenterology|June 21, 2017
Corrigendum: Treatment of NASH: What Helps Beyond Weight Loss?Bubu A Banini, Arun J Sanyal
Current Opinion in Gastroenterology|March 28, 2017
Current and future pharmacologic treatment of nonalcoholic steatohepatitisBubu A Banini, Arun J Sanyal
Advances in Cancer Research|February 13, 2021
NAFLD-related HCCBubu A Banini, Arun J Sanyal
Hepatoma Research|November 2, 2019
The use of cell free DNA in the diagnosis of HCCBubu A Banini, Arun J Sanyal
Current Treatment Options in Gastroenterology|May 12, 2019
Updates on Chronic HBV: Current Challenges and Future GoalsHannah M Lee, Bubu A Banini
Clinical Medicine Insights. Therapeutics|July 4, 2017
Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment OptionsBubu A Banini, Arun J Sanyal
Digestive Diseases and Sciences|May 9, 2022
Hepatic Hydrothorax: An Independent Predictor of Mortality in Cirrhosis? Is the MELD-Na Score Worth Its Salt?Jennifer C Asotibe, Bubu A Banini
The American Journal of Gastroenterology|April 12, 2017
Treatment of NASH: What Helps Beyond Weight Loss?Bubu A Banini, Arun J Sanyal
Annals of the New York Academy of Sciences|July 3, 2023
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategiesGeorge Agyapong, Farzaneh Dashti, Bubu A Banini
Frontiers in Oncology|August 8, 2022
Editorial: Recent advances in the understanding of hepatocellular carcinogenesisBubu A Banini, Rohini Mehta, Prasanna K Santhekadur
Pageof 4